Literature DB >> 9018965

Immune correlates of protection from HIV infection and AIDS.

J L Heeney1, C Bruck, J Goudsmit, L Montagnier, A Schultz, D Tyrrell, S Zolla-Pazner.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1997        PMID： 9018965     DOI： 10.1016/s0167-5699(97)80005-9

Source DB:  PubMed          Journal:  Immunol Today        ISSN： 0167-5699


× No keyword cloud information.
  8 in total

1.  Increased neutralization sensitivity and reduced replicative capacity of human immunodeficiency virus type 1 after short-term in vivo or in vitro passage through chimpanzees.

Authors:  T Beaumont; S Broersen; A van Nuenen; H G Huisman; A M de Roda Husman; J L Heeney; H Schuitemaker
Journal:  J Virol       Date:  2000-09       Impact factor: 5.103

2.  beta-chemokines and neutralizing antibody titers correlate with sterilizing immunity generated in HIV-1 vaccinated macaques.

Authors:  J L Heeney; V J Teeuwsen; M van Gils; W M Bogers; C De Giuli Morghen; A Radaelli; S Barnett; B Morein; L Akerblom; Y Wang; T Lehner; D Davis
Journal:  Proc Natl Acad Sci U S A       Date:  1998-09-01       Impact factor: 11.205

3.  Patient-specific cytotoxic T-lymphocyte cross-recognition of naturally occurring variants of a human immunodeficiency virus type 1 (HIV-1) p24gag epitope by HIV-1-infected children.

Authors:  F Buseyne; M L Chaix; C Rouzioux; S Blanche; Y Rivière
Journal:  J Virol       Date:  2001-05       Impact factor: 5.103

4.  Comparison of immunity generated by nucleic acid-, MF59-, and ISCOM-formulated human immunodeficiency virus type 1 vaccines in Rhesus macaques: evidence for viral clearance.

Authors:  E J Verschoor; P Mooij; H Oostermeijer; M van der Kolk; P ten Haaft; B Verstrepen; Y Sun; B Morein; L Akerblom; D H Fuller; S W Barnett; J L Heeney
Journal:  J Virol       Date:  1999-04       Impact factor: 5.103

5.  Immunogenicity of an anti-clade B feline immunodeficiency fixed-cell virus vaccine in field cats.

Authors:  D Matteucci; A Poli; P Mazzetti; S Sozzi; F Bonci; P Isola; L Zaccaro; S Giannecchini; M Calandrella; M Pistello; S Specter; M Bendinelli
Journal:  J Virol       Date:  2000-12       Impact factor: 5.103

6.  Evidence for viral virulence as a predominant factor limiting human immunodeficiency virus vaccine efficacy.

Authors:  P Mooij; W M Bogers; H Oostermeijer; W Koornstra; P J Ten Haaft; B E Verstrepen; G Van Der Auwera; J L Heeney
Journal:  J Virol       Date:  2000-05       Impact factor: 5.103

7.  Puma lentivirus is controlled in domestic cats after mucosal exposure in the absence of conventional indicators of immunity.

Authors:  Julie A Terwee; Jennifer K Yactor; Kerry S Sondgeroth; Sue Vandewoude
Journal:  J Virol       Date:  2005-03       Impact factor: 5.103

8.  AIDS vaccination studies using an ex vivo feline immunodeficiency virus model: detailed analysis of the humoral immune response to a protective vaccine.

Authors:  P Mazzetti; S Giannecchini; D Del Mauro; D Matteucci; P Portincasa; A Merico; C Chezzi; M Bendinelli
Journal:  J Virol       Date:  1999-01       Impact factor: 5.103
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.